Glow Blend (70 mg: BPC-157 / TB-500 / GHK-Cu) Dosage Protocol
Reconstitution and dosing guide for the Glow Blend, a 70 mg recovery-and-skin stack combining 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu in a single vial (a 1 : 1 : 5 ratio of BPC : TB : GHK).
Quickstart Highlights
Glow Blend pairs two tissue-repair peptides with the copper peptide GHK-Cu in one vial. BPC-157 and TB-500 are studied for soft- and connective-tissue recovery, while GHK-Cu is researched for skin remodeling, collagen synthesis, and antioxidant support, together marketed as a “glow” recovery stack. Because all three components share one vial in a fixed 1 : 1 : 5 ratio, every subcutaneous dose delivers all three proportionally.
- Composition: 70 mg total per vial → 10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu
- Reconstitute: Add 2.0 mL bacteriostatic water → 35 mg/mL total blend (≈5 mg/mL BPC, 5 mg/mL TB, 25 mg/mL GHK-Cu)
- Easy measuring: At this concentration, 1 unit (0.01 mL) on a U-100 syringe ≈ 50 mcg BPC + 50 mcg TB + 250 mcg GHK
- Storage: Lyophilized: −20 °C (−4 °F); reconstituted: 2–8 °C (35.6–46.4 °F), protected from light, use within 2–4 weeks
Dosing & Reconstitution Guide
Daily subcutaneous protocol; each dose below is a single injection of the combined blend
Subcutaneous Protocol (70 mg vial, 2 mL = 35 mg/mL total)
| Phase | Blend Volume | Delivers (BPC / TB / GHK) | Units (U-100) |
|---|---|---|---|
| Intro (Weeks 1–2) | 0.02 mL | 100 / 100 / 500 mcg | 2 units |
| Standard (Weeks 3–8) | 0.04 mL | 200 / 200 / 1000 mcg | 4 units |
| Maintenance | 0.04 mL, 5×/week | 200 / 200 / 1000 mcg | 4 units |
Administration: Once daily via subcutaneous injection, rotating sites. At the standard 0.04 mL dose, a 70 mg vial provides roughly 50 daily doses. Note: GHK-Cu solutions are normally tinted blue from the copper complex; this is expected and not a sign of contamination.
Reconstitution Steps
- Allow the vial to reach room temperature (15–20 minutes out of cold storage).
- Draw 2.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall to avoid foaming.
- Gently swirl or roll until fully dissolved (do not shake).
- Label with date and concentration; refrigerate at 2–8 °C, protected from light.
Result: ≈35 mg/mL total blend (≈5 mg/mL BPC-157, 5 mg/mL TB-500, 25 mg/mL GHK-Cu)
How This Works
BPC-157 is a synthetic pentadecapeptide studied for accelerating repair of tendon, ligament, muscle, and gut tissue, partly by promoting angiogenesis and growth-factor signaling. TB-500, a synthetic fragment of thymosin β-4, is researched for actin regulation, cell migration, and new blood-vessel formation that supports broader tissue regeneration.
GHK-Cu (copper tripeptide-1) is studied for stimulating collagen and elastin synthesis, skin remodeling, and antioxidant activity. Combining the two repair peptides with GHK-Cu is intended to pair systemic tissue recovery with skin and cosmetic “glow” effects in a single fixed-ratio preparation.
Key Administration Notes
- Rotate injection sites (abdomen, thighs, upper arms) to prevent lipohypertrophy.
- Because the ratio is fixed, dosing for one component automatically sets the others, target your dose around the GHK-Cu amount you want.
- Use new sterile insulin syringes each time; dispose in a sharps container.
- Document daily dose, date, and site for consistency.
References
Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in the treatment of tissue injury. View Source
Goldstein AL, et al. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. View Source
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. View Source
⚠️ Research & Educational Purposes Only
This information is provided for research and educational purposes only. The peptides discussed are intended for laboratory research use only and are not approved for human consumption. Always consult qualified healthcare professionals for medical advice. Individual results may vary. This is not medical advice.